TGFB1 and non-small cell lung carcinoma: In a Chinese study presented at the last American Society for Clinical Oncology Congress, a comparison of global gene expression patterns of non‐small‐cell lung carcinoma (NSCLC) cells treated with and without TGF‐β demonstrated 423 lncRNAs to be upregulated and 246 downregulated in TGF‐β‐treated cells compared with control cells.